Join
Live feed
·
INSIDERFilingvia Quantisnow
Teva Pharmaceutical Industries Limited logo

EVP, Europe Commercial Daniell Richard converted options into 53,973 units of Ordinary Shares and sold $2,983,517 worth of Ordinary Shares (91,345 units at $32.66), decreasing direct ownership by 30% to 85,755 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEVA (Teva Pharmaceutical Industries Limited) and more on Quantisnow.